Houston, TX (PRWEB) August 2, 2008
Tysabri side effects lawyers Pulaski & Middleman announce the launch of a website dedicated to assisting people who are suffering serious side effects as a result of taking Tysabri (natalizumab).
Tysabri, a drug used to treat multiple sclerosis (MS) and Crohn's disease, is marketed by Irish drug company Elan and US biotechnology firm Biogen Idec.
In 2005, Tysabri was briefly pulled out of the market after three patients participating in clinical trials contracted progressive multifocal leukoencephalopathy (PML), a rare but deadly viral brain infection. Although the drug was eventually re-released, two more cases of PML were reported in mid-2008, raising more concerns about Tysabri's safety and side effects.
The U.S. Food and Drug Administration (FDA) has also warned that Tysabri has the potential to cause serious liver damage leading to death or the need for a liver transplant.
As experienced litigators, Tysabri lawyers Pulaski & Middleman stand ready to assist people who have been adversely affected by this potentially dangerous drug.
About Pulaski & Middleman:
A Houston-based law firm, Pulaski & Middleman has successfully resolved thousands of cases and helped countless clients during its 15-year history. They pride themselves in a personal approach to even the most complicated cases, including medical malpractice, product liability, and other areas of personal injury law.
If you or someone you love is suffering from the side effects of Tysabri, contact Pulaski & Middleman at http://www.tysabrilawsuitattorney.com and discuss your case with a Tysabri attorney today.